Last updated: September 28, 2023
Sponsor: University College Cork
Overall Status: Active - Recruiting
Phase
N/A
Condition
Cerebral Palsy
Neuronal Ceroid Lipofuscinoses (Ncl)
Holoprosencephaly
Treatment
N/AClinical Study ID
NCT05907837
EDI-CPI
Ages < 40 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Legal guardians must be able and willing to give written informed consent and tocomply with the requirements of this study protocol.
- All infants considered high risk for cerebral palsy and neuro-developmental impairmentwill be eligible, specifically including:
- All preterm infants born ≤32 weeks Post Menstrual Age or ≤1500 gm birth weight
- All encephalopathic infants
- Neurological risk factors (e.g., injury/malformation on neuroimaging,persistently abnormal neurological exam)
Exclusion
Exclusion Criteria:
- Death prior to discharge from the neonatal unit.
Study Design
Total Participants: 1500
Study Start date:
July 01, 2023
Estimated Completion Date:
June 30, 2028
Connect with a study center
Cork University Maternity Hospital
Cork,
IrelandActive - Recruiting
Coombe Women and Infants University Hospital
Dublin,
IrelandActive - Recruiting
National Maternity Hospital
Dublin,
IrelandActive - Recruiting
The Rotunda Hospital
Dublin,
IrelandActive - Recruiting
University Maternity Hospital Limerick
Limerick,
IrelandSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.